For comments, suggestions
Created with Raphaël 2.1.0 17.12.2015 Filing date 04.07.2017 Validation fee payment 31.01.2018 (A1) Patent application published 09.04.2019 AGEPI application filing date 31.07.2019 (T2) Translation of the validated European patent 31.03.2021 (MM4E) Forfeiture of rights 31.03.2022 (MM4E) Forfeiture of rights

Patent lapsed


(210)Number of the EPO application15823875
(220)Filing date of the EPO application2015.12.17
(80)EPO patent specification publication (B)EPB nr. 05/2019, 2019.01.30
(110)EPO patent number3233803
(11)Number of the documentMD 3233803 T2
(21)Number of the applicatione 2017 0208
(71)Name(s) of applicant(s), code of the countryAragon Pharmaceuticals, Inc., US;
(72)Name(s) of inventor(s), code of the countryHAIM Cyril Ben, BE;
HORVATH Andras, BE;
WEERTS Johan Erwin Edmond, BE;
(73)Name(s) of owner(s), code of the countryARAGON Pharmaceuticals Inc., US;
(54)Title of the inventionProcess for the preparation of a diarylthiohydantoin compound
(13)Kind-of-document code T2
(51)International Patent Classification C07D 213/84 (2006.01.01); C07D 401/04 (2006.01.01); C07D 213/61 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2018.01.31
(49)Date of publication of the translation of the validated European patent specification2019.07.31
(30)Priority201462094436 P, 2014.12.19, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2015/066356, 2015.12.17
(87)International publicationWO 2016/100652, 2016.06.23
Up
/Inventions/details/3233803